• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION WATCHMAN FLX? Pro; system, appendage closure, left atrial

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION WATCHMAN FLX? Pro; system, appendage closure, left atrial Back to Search Results
Model Number M635WU60270
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Pericardial Effusion (3271)
Date of Event 09/14/2026
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that pericardial effusion occurred.A left atrial appendage closure procedure was being performed.Transseptal puncture was performed with a versacross connect and a watchman fxd double curve access system.Difficulty was noted in obtaining transseptal puncture.A 27mm watchman flx pro closure device was implanted.Post-implant, a pericardial effusion was noted around the ventricle during the final sweep.Additional protamine was administered and the patient was monitored on the table with physician present.The patient was still intubated, and transesophageal echocardiography was still in place.Transthoracic echocardiogram was performed as well.After some time, the physician determined the pericardial effusion was not large enough for additional treatment and the patient was sent to the recovery unit.A few hours later, a pericardiocentesis was performed.A drain was placed and the patient was kept overnight for observation.The next day, the patient was confirmed to be doing well and was discharged.The physician believed the pericardial effusion had been caused during transseptal puncture.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
WATCHMAN FLX? Pro
Common Device Name
system, appendage closure, left atrial
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
Boston Scientific Corporation
ballybrit business park
galway H91 Y 868
EI   H91 Y868
Manufacturer Contact
mary crawford
4100 hamline ave n
arden hills, MN 55112
+1(651)440-0979
MDR Report Key50810128
Report Number2124215-2026-49811
Device Sequence Number10581086
Product Code NGV
UDI-Device Identifier00191506004606
UDI-Public(01)00191506004606(17)290624(10)39671656
Combination Product (Y/N)N
Initial Reporter StateAR
Initial Reporter CountryUS
PMA/510(K) Number
P130013
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2026
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 09/17/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Model NumberM635WU60270
Device Catalogue NumberM635WU60270
Device Lot Number0039671656
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 09/14/2026
Initial Report FDA Received Date09/17/2026
Date Device Manufactured06/25/2026
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Hospitalization; Required Intervention;
Patient Age81 YR
Patient SexFemale
-
-